US appeals court revives 500 Tylenol-autism lawsuits against Kenvue
Why it matters: The ruling could open Kenvue to thousands more claims and billions in potential settlement costs.
Why it matters: The ruling could open Kenvue to thousands more claims and billions in potential settlement costs.
What’s new: A 2nd Circuit panel rejected his trial challenge, leaving in place convictions tied to about $8 billion in customer losses.